Doximity (NASDAQ:DOCS – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a report released on Friday,Finviz reports. The firm presently has a $40.00 target price on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 20.12% from the company’s current price.
A number of other brokerages also recently issued reports on DOCS. Royal Bank Of Canada assumed coverage on Doximity in a report on Thursday, January 8th. They issued an “outperform” rating and a $59.00 price target on the stock. Truist Financial cut their target price on Doximity from $62.00 to $37.00 and set a “buy” rating on the stock in a research note on Friday. Raymond James Financial reissued a “strong-buy” rating on shares of Doximity in a research report on Monday, December 29th. Morgan Stanley raised shares of Doximity from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $62.00 to $65.00 in a research report on Monday, December 15th. Finally, Needham & Company LLC reduced their price target on Doximity from $75.00 to $55.00 and set a “buy” rating on the stock in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $57.47.
View Our Latest Report on DOCS
Doximity Trading Down 5.5%
Doximity (NASDAQ:DOCS – Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period last year, the company posted $0.45 earnings per share. On average, equities research analysts predict that Doximity will post 0.99 EPS for the current year.
Doximity declared that its board has initiated a stock repurchase plan on Thursday, February 5th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
Institutional Investors Weigh In On Doximity
A number of large investors have recently bought and sold shares of DOCS. Voya Investment Management LLC boosted its holdings in shares of Doximity by 932.8% in the 3rd quarter. Voya Investment Management LLC now owns 1,567,668 shares of the company’s stock valued at $114,267,000 after acquiring an additional 1,415,882 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in Doximity by 325,436.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock worth $57,515,000 after acquiring an additional 1,298,492 shares during the period. Franklin Resources Inc. grew its holdings in Doximity by 53.9% during the second quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock worth $193,993,000 after acquiring an additional 1,108,162 shares during the period. Capital World Investors raised its position in Doximity by 25.7% during the third quarter. Capital World Investors now owns 5,381,431 shares of the company’s stock valued at $393,652,000 after acquiring an additional 1,101,848 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Doximity by 525.3% in the third quarter. Victory Capital Management Inc. now owns 1,096,965 shares of the company’s stock valued at $80,243,000 after acquiring an additional 921,533 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.
Key Headlines Impacting Doximity
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: Doximity announced a $500 million share buyback authorization (about 8% of shares outstanding), a signal the board views the stock as undervalued and a potential support for the equity over time. RTT News
- Positive Sentiment: Operational engagement metrics were highlighted as strong: record workflow-product adoption (720,000 users QoQ jump) and 1M+ quarterly active prescribers; early AI products show user traction — positive for long‑term monetization. Business Wire
- Positive Sentiment: Doximity was ranked #1 Best in KLAS Telehealth Video Platform for the fifth consecutive year — supportive for competitive positioning in telehealth workflows. 01net
- Neutral Sentiment: Q3 results: revenue $185.05M (+~10% YoY) and EPS $0.46, both slightly above consensus — beats were modest rather than transformative. Analysts are digging into key metrics for guidance implications. Benzinga
- Neutral Sentiment: A full earnings/management transcript is available for deeper read on product cadence, sales dynamics, and AI roadmap for investors wanting color beyond the headlines. Seeking Alpha transcript
- Negative Sentiment: Management lowered Q4 and FY2026 revenue guidance: Q4 $143.0M–$144.0M vs. consensus ~$150.2M and FY revenue guided slightly below consensus (~$642.5M–$643.5M vs. ~$645.3M). The softer outlook was the primary catalyst for a sharp after‑hours selloff. Business Wire guidance
- Negative Sentiment: Market reaction: shares plunged heavily after the print and guidance miss, reflecting investor sensitivity to near‑term growth deceleration despite buyback and solid engagement metrics. MSN market coverage
Doximity Company Profile
Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”
The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.
Further Reading
- Five stocks we like better than Doximity
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
